| Literature DB >> 31344982 |
Hope A Igboeli1, Douglas H Marchbank1,2, Hebelin Correa2, David Overy1,3, Russell G Kerr4,5,6.
Abstract
Advances in whole-genome sequencing of many fungal species has revealed the presence of numerous "silent" biosynthetic genes, highlighting their potential to produce a wide variety of natural products. These silent biosynthetic genes are regulated in part by their highly condensed chromatin structure, which can be modified to allow transcription in response to external stimuli. In this study, Asteromyces cruciatus was subjected to both epigenetic modification and osmotic stress to enhance the production of new natural products. This "cooperative induction" strategy led to the isolation and characterization of two new polyketides from a fermentation of A. cruciatus treated with suberoylanilide hydroxamic acid and sodium chloride. The metabolic profiles of the control and treated samples were assessed using ultra-high performance liquid chromatography high-resolution electrospray ionization mass spectrometry (UHPLC-HRESIMS) metabolomic analysis, highlighting the upregulation of two new polyketides, primarolides A and B. These compounds were purified using reversed-phase flash chromatography followed by high-performance liquid chromatography, and their planar structures were established using NMR spectroscopy.Entities:
Keywords: Asteromyces cruciatus; epigenetic modification; metabolomics; natural product; silent biosynthetic gene clusters
Year: 2019 PMID: 31344982 PMCID: PMC6723326 DOI: 10.3390/md17080435
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
A. cruciatus fermentation treatment conditions.
| Group No. | SAHA (µM) | 5-aza (µM) | H2O2 (nM) | NaCl (M) |
|---|---|---|---|---|
| 1 | - | - | - | - |
| 2 | 10 | - | - | - |
| 3 | 100 | - | - | - |
| 4 | - | 10 | - | - |
| 5 | - | 100 | - | - |
| 6 | - | - | 100 | - |
| 7 | - | - | - | 1.25 |
| 8 | 100 | - | 100 | - |
| 9 | - | 100 | 100 | - |
| 10 | 100 | - | - | 1.25 |
| 11 | - | 100 | - | 1.25 |
| 12 | 100 | 100 | - | - |
SAHA: suberoylanilide hydroxamic acid; 5-aza: 5-azacytidine.
Figure 1Heat map of UHPLC-HRESIMS metabolomics data showing mass features (MF) significantly different than the control groups (n = 3). The rows represent each of the treatment conditions as defined in Table 1, while the horizontal axis represents significant mass features (m/z_Rt) summarized in Table S1. Peak areas were normalized with blue cells representing peak areas less than or equal to the detection threshold (2 × 104), while red cells represent peak areas in the treatment with the highest production level. The black box highlights mass features representing primarolides A (1) and B (2).
Figure 2Production of primarolides A (1) and B (2) across five treatment conditions (n = 6) represented by normalized peak areas.
NMR spectroscopic data (1H NMR: 600 MHz, 13C NMR: 151 MHz, CD3OD) for primarolide A (δ in ppm relative to the residual solvent signal).
| Position | δC, Type | δH, Mult ( | COSY | HMBC | |
|---|---|---|---|---|---|
| 1 | |||||
| 2 | 77.2 | C | |||
| 3 | 128.3 | CH | 5.33, d (9.8) | 4 | 2, 4a, 17 |
| 4 | 122.7 | CH | 6.16, d (9.8) | 3 | 2, 3, 4a, 5, 8a |
| 4a | 115.4 | C | |||
| 5 | 128.7 | CH | 6.83, d (8.3) | 6 | 4, 7, 8a, |
| 6 | 108.4 | CH | 6.42, d (8.3) | 5 | 4a, 8 |
| 7 | 157.9 | C | |||
| 8 | 111.2 | C | |||
| 8a | 154.7 | C | |||
| 9 | 75.0 | CH | 6.99, br s | 7, 8, 8a, 11, 11a, 15a | |
| 10 | |||||
| 11 | 173.2 | C | |||
| 11a | 144.3 | C | |||
| 12 | 153.4 | C | |||
| 13 | 146.7 | C | |||
| 14 | 141.6 | C | |||
| 15 | 118.8 | CH | 6.72, br s | 11, 12, 13, 15a | |
| 15a | 113.6 | C | |||
| 16 | 26.8 | CH3 | 0.65, s | 2, 3, 17 | |
| 17 | 27.9 | CH3 | 1.17, s | 2, 3, 16 | |
| 18 | 60.6 | CH3 | 3.43, s | 13 | |
| 19 | 16.4 | CH3 | 2.23, s | 13, 14, 15 | |
See Figures S1–S5 for NMR spectra. COSY and HMBC correlations shown were from proton(s) stated with the indicated proton and carbon, respectively.
Figure 3Chemical structure of primarolide A (1) showing (a) numbered positions and (b) key HMBC (1H → 13C) and COSY (bold bonds) correlations.
NMR spectroscopic data (1H NMR: 600 MHz, 13C NMR: 151 MHz, CD3OD) for primarolide B (δ in ppm relative to the residual solvent signal).
| Position | δC, Type | δH, Mult ( | COSY | HMBC | |
|---|---|---|---|---|---|
| 1 | |||||
| 2 | 76.8 | C | |||
| 3 | 127.8 | CH | 5.24, d, (9.7) | 4 | 2, 4a, 16 |
| 4 | 122.9 | CH | 6.04, d, (9.7) | 3 | 2, 4a, 5, 8a |
| 4a | 115.4 | C | |||
| 5 | 127.5 | CH | 6.62, d, (8.2) | 6 | 7, 8, 8a |
| 6 | 108.4 | CH | 6.26, d, (8.2) | 5 | 4a, 7, 8 |
| 7 | 158.4 | C | |||
| 8 | 111.2 | C | |||
| 8a | 154.0 | C | |||
| 9 | 56.1 | CH | 6.68, d (0.6) | 7, 8, 8a, 11, 11a, 12, 15a | |
| 10 | |||||
| 11 | 168.9 | C | |||
| 11a | 132.1 | C | |||
| 12 | 149.4 | C | |||
| 13 | 149.9 | C | |||
| 14 | 133.1 | C | |||
| 15 | 122.2 | CH | 6.77, d (0.6) | 9, 11a, 13, 14, 19 | |
| 15a | 126.9 | C | |||
| 16 | 26.5 | CH3 | 0.61, s | 2, 3, 17 | |
| 17 | 28.9 | CH3 | 1.18, s | 2, 3, 16 | |
| 18 | 15.6 | CH3 | 2.28, s | 13, 14, 15 | |
| 19 | 62.5 | CH3 | 3.96, s | 13 | |
| 20 | 139.3 | C | |||
| 21 | 124.1 | CH | 7.69, app. d (8.5) | 22 | 20, 22 |
| 22 | 129.3 | CH | 7.27, app. dd (7.5, 8.5) | 21, 23 | 20, 23 |
| 23 | 125.9 | CH | 7.07, app. t (7.5) | 22 | 21, 22 |
See Figures S7–S12 for NMR spectra. COSY and HMBC correlations shown were from proton(s) stated with the indicated proton and carbon, respectively.
Figure 4Chemical structure of Primarolide B (2) showing (a) numbered positions and (b) key HMBC (1H → 13C) and COSY (bold bonds) correlations.